Compare FEMY & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | TACT |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 37.2M |
| IPO Year | 2021 | 1996 |
| Metric | FEMY | TACT |
|---|---|---|
| Price | $0.57 | $3.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $5.50 | $5.00 |
| AVG Volume (30 Days) | ★ 407.0K | 22.2K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.60 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,629,108.00 | N/A |
| Revenue This Year | $64.02 | $21.67 |
| Revenue Next Year | $147.19 | $7.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.97 | N/A |
| 52 Week Low | $0.31 | $3.22 |
| 52 Week High | $1.76 | $5.70 |
| Indicator | FEMY | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 33.34 |
| Support Level | $0.54 | N/A |
| Resistance Level | $0.58 | $3.89 |
| Average True Range (ATR) | 0.03 | 0.19 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 80.26 | 12.50 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.